StockData
Attovia Therapeutics, Inc. logo

Attovia Therapeutics, Inc. (ATTO) stock

ATTONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026
$14.86+0.13 (+0.92%)

Close on Nov 17, 2026Market cap $678.38MP/E –Yield –

Attovia Therapeutics total assets

Total assets on the balance sheet at the end of each period.

Attovia Therapeutics's total assets was $411.82M at Sep 30, 2026. For fiscal 2025 it was $165.89M.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$165.89M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$411.82M–
Q2 FY2026Jun 30, 2026$128.35M–
Q4 FY2025Dec 31, 2025$165.89M–

More Attovia Therapeutics figures

See a number that looks wrong?